Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-01-08 @ 5:37 PM
Study NCT ID:
NCT02924233
Status:
WITHDRAWN
Last Update Posted:
2017-08-28
First Post:
2016-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Sponsor:
Symphogen A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-28
First Submit QC Date:
None
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-25
Last Update Post Date:
2017-08-28
Last Update Post Date Type:
ACTUAL